Product Information
| Product Name | FOXO4-DRI |
| Batch Number | PH-FOXO4-001-2025-1646 |
| Analysis Date | 2025-01-15 |
Analytical Methods
- Third-Party Laboratory Analysis
Test Results
| Parameter | Result |
|---|---|
| Purity (HPLC) | ≥99% |
| Molecular Mass | 3400 Da |
Conclusion
This product has been independently verified by a third-party laboratory. Click the verification link below to view the complete lab report.
Third-Party Verification
This product has been independently tested by Janoshik Analytical. View the full lab report:
View Janoshik Lab ReportPeptide Hackers Laboratory Standards for FOXO4-DRI
FOXO4-DRI is synthesized and analyzed in controlled laboratory environments operating under documented quality management systems aligned with ISO 9001:2015 principles. This ensures standardized procedures, batch traceability, record control, and consistent quality oversight across production and testing.
Each batch of FOXO4-DRI undergoes analytical verification using High Performance Liquid Chromatography HPLC to assess purity and Mass Spectrometry MS to confirm molecular identity. The Certificate of Analysis reflects the actual test results for the specific lot shown.
ISO 9001:2015 relates to how quality systems are managed and audited. It does not represent pharmaceutical grade GMP. FOXO4-DRI is not marketed as an FDA approved drug and is supplied strictly for research purposes only.
This document is provided for informational and research reference purposes. No purchase, ordering, or commercial transaction information is contained herein.